AEGERION PHARMACEUTICALS INC's ticker is and the CUSIP is 00767EAB8. A total of 14 filers reported holding AEGERION PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 5.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,825,000 | -10.5% | 7,200,000 | 0.0% | 0.15% | -39.5% |
| Q4 2018 | $5,391,000 | -0.1% | 7,200,000 | 0.0% | 0.24% | +48.2% |
| Q3 2018 | $5,395,000 | -12.5% | 7,200,000 | -24.2% | 0.16% | -17.6% |
| Q2 2018 | $6,165,000 | +176.6% | 9,500,000 | +143.0% | 0.20% | +237.3% |
| Q2 2016 | $2,229,000 | -25.8% | 3,910,000 | -33.8% | 0.06% | -33.0% |
| Q1 2016 | $3,003,000 | +352.3% | 5,910,000 | +491.0% | 0.09% | +388.9% |
| Q4 2015 | $664,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 24,200,000 | $15,957,000 | 13.01% |
| Telemetry Investments, L.L.C. | 7,000,000 | $4,616,000 | 2.90% |
| Context Capital Management, LLC | 2,760,000 | $1,826,000 | 1.78% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 67,567,000 | $45,228,000 | 0.72% |
| Tekla Capital Management LLC | 13,000,000 | $8,572,000 | 0.33% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 30,500,000 | $20,035,000,000 | 0.30% |
| Baker Brothers Advisors | 26,517,000 | $17,432,000 | 0.16% |
| FALCON POINT CAPITAL, LLC | 1,500,000 | $937,000 | 0.14% |
| CSS LLC/IL | 1,753,000 | $1,170,000 | 0.06% |
| K2 PRINCIPAL FUND, L.P. | 8,325 | $8,325,000 | 0.02% |